3. What's Wrong With Topical Diclofenac? | Dr. Raimar Loebenberg - Leaders in Healthcare

We appreciate the importance of technological breakthroughs in advancing patient care at Cherry Health. When we heard about the next-generation nanotechnology base RS Therapeutics had developed for prescription delivery methods of compounding topical anti-inflammatories we needed to learn more!

‍More on...

Our website: https://www.cherry.health/

LinkedIn: https://www.linkedin.com/company/cherry-health-inc/

Facebook: https://www.facebook.com/cherryhealthinc/

Instagram: @cherry.health